CD8A and cancer: To validate the clinical utility of their classification system, they analyzed the topography of CD8+ lymphocytes and CD163+ macrophages in colorectal cancer (CRC) primary tumors because these cell types were previously shown to be linked to prognosis (17) and also showed discordant topographies in their pan-cancer cohort.